Carbamazepine Tablets 200mg
Taro recalls Carbamazepine 200mg tablets over black specks.
Consumers who have the affected Carbamazepine Tablets, USP, 200mg, 1000-count bottles should stop using them and contact their pharmacist or healthcare provider for a replacement or further instructions. Return the product to the place of purchase for a refund or exchange.
Recall at a glance
- Quantity recalled
- 1968 Bottles (1000Tablets/Bottle)
Why it was recalled
Taro Pharmaceuticals is recalling Carbamazepine Tablets, USP, 200mg, 1000-count bottles, due to a complaint report regarding tablets with black specks. The tablets may contain foreign particulate matter, posing a potential health risk.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Carbamazepine Tablets, USPStrength: 200 mgNDC / UPC: NDC 51672-4005-3
| Lot code |
|---|
| – |
| AD94033, 2028 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Product Quality Defect recalls
Other recent recalls from SUN PHARMACEUTICAL INDUSTRIES INC
Editorial summary by Recall Canary · summary updated 2026-08-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification